CphI & P-Mec India

Express Pharma (May 15-31, 2017) EXPANDING ACCESS Express Pharma has always taken a keen interest in India’s progress in the…

Deal value decreases to $7.1 billion when compared five months average of $10.6 billion

Increased market diversification is expected due to patent expiries for major insulin products

The drug is already approved for patients who have been treated with Pfizer's lung cancer drug Xalkori

The burden of diagnosed Crohn’s Disease (CD) is expected to grow between 2016 and 2026 in the seven major markets

The company anticipates a steady stream of novel therapies to enter the OA marketplace over the next 10 years

Trends indicate that medical tourism will also bolster the demand for sophisticated devices

The immunotherapy Kymriah is a key element of Novartis’s efforts to bolster its portfolio of oncology drugs

The decision by the Food and Drug Administration paves the way for a speedy regulatory review of the BCMA drug for multiple…

Certain bacteria seem to help in cancer by priming immune cells and smoothing the path for immunotherapy drugs known as PD-1 drugs